Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

MYFEMBREE 40 MG

RELUGOLIX : 40 MG ESTRADIOL : 1 MG NORETHINDRONE ACETATE : 0.5 MG · DIN 02541742 · SUMITOMO PHARMA SWITZERLAND GMBH

Health Canada status: MARKETED

What is MYFEMBREE?

MYFEMBREE 40 MG contains RELUGOLIX : 40 MG ESTRADIOL : 1 MG NORETHINDRONE ACETATE : 0.5 MG. It is listed in the Health Canada Drug Product Database under DIN 02541742, held by SUMITOMO PHARMA SWITZERLAND GMBH, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 28-Oct-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is MYFEMBREE used for?

MYFEMBREE (relugolix, estradiol, and norethindrone acetate tablets) is indicated in premenopausal women for the management of heavy menstrual bleeding associated with uterine fibroids and for the management of moderate to severe pain associated with endometriosis.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02541742
Brand nameMYFEMBREE
Generic / active ingredientRELUGOLIX : 40 MG ESTRADIOL : 1 MG NORETHINDRONE ACETATE : 0.5 MG
ManufacturerSUMITOMO PHARMA SWITZERLAND GMBH
Strength40 MG
Dosage formTABLET
Route of administrationORAL
SchedulePrescription
ATC codeH01CC54 RELUGOLIX, ESTRADIOL AND NORETHISTERONE
BiosimilarNo
Health Canada statusMARKETED
Status date28-Oct-2025

How is it stored and handled?

null

How is it supplied?

28-count HDPE bottles and 7-count HDPE bottles with desiccant.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for MYFEMBREE

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for MYFEMBREE

Health Canada Drug Product Database (DPD), DIN 02541742. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.